Friday, June 26, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 806 of 1,261
  1. US 8772483

    Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  2. US 8772479

    Oligomer-containing substituted aromatic triazine compounds

    Nektar Therapeutics · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  3. US 8772482

    4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  4. US 8772306

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals, Inc. · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  5. US 8771965

    Methods and compositions involving nucleotide repeat disorders

    The Board of Regents of the University of Texas System · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  6. US 8771662

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  7. EP 2747770

    BEHANDLUNGEN MIT ESLICARBAZEPINACETAT ODER ESLICARBAZEPIN

    BIAL PORTELA & C S A [PT] · Granted Jul 2, 2014 · Expires Jun 27, 2034

    granted
  8. US 8765957

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  9. US 8765932

    Compositions and methods for inhibiting expression of XBP-1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  10. US 8765933

    Asynthesis of β-nucleosides

    PHARMAESSENTIA CORPORATION · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  11. US 8768431

    Systems and methods for tissue imaging

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  12. US 8765945

    Processes of synthesizing dihydropyridophthalazinone derivatives

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  13. US 8765948

    Processes for the preparation of uracil derivatives

    Neurocrine Biosciences, Inc. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  14. US 8765935

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  15. US 8765909

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  16. US 8765680

    Method for administering omega-conopeptide

    Jazz Pharmaceuticals International III Limited · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  17. US 8765761

    6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitor

    GILEAD CONNECTICUT, INC. · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  18. US 8765731

    Benzimidazole analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  19. US 8765176

    Method of manufacturing tablet

    Takeda Pharmaceutical Company Limited · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  20. US 8765813

    Use of treprostinil to treat and prevent ischemic lesions

    United Therapeutics Corporation · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  21. US 8765883

    Stabilized polymeric thiol reagents

    Nektar Therapeutics · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  22. US 8765751

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  23. US 8765673

    Methods for promoting wound healing and/or reducing scar formation

    THE ARIZONA BOARD OF REGENTS · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  24. US 8765146

    Adenoviral vector-based malaria vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.